Literature DB >> 29736203

MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression.

Zhouhui Ren1,2, Tong Yang2, Jie Ding1, Weihong Liu1, Xiangyu Meng1, Pingping Zhang3, Kaitai Liu4, Ping Wang1.   

Abstract

MicroRNAs (miRNAs) play an important role in human tumorigenesis as oncogenes or tumor suppressors by directly binding to the 3'-untranslated region of their target mRNAs. MiR-520d-3p has been reported as a tumor suppressor gene in ovarian cancer and gastric cancer, while the function of miR-520d-3p in human breast cancers is still uninvolved. In this study, we initially identified that the expression of miR-520d-3p was significantly reduced in breast cancer specimens and cell lines. The restoration of miR-520d-3p expression not only reduced breast cancer cell viability by causing the accumulation of G2 phase and cell apoptosis, but also inhibited tumorigenicity in vivo. In addition, as a critical target of miR-520d-3p, the activity of spindle and kinetochore associated 2 (SKA2) was greatly inhibited by miR-520d-3p, and overexpression of miR-520d-3p decreased the expression of SKA2. SKA2 downregulation suppressed cell viability, whereas restoration of SKA2 expression significantly reversed the inhibitory effects of miR-520d-3p antitumor activity. Furthermore, SKA2 was frequently overexpressed in clinical specimens and cell lines, and the expression levels were statistically inversely correlated with miR-520d-3p expression. In conclusion, our data demonstrated that miR-520d-3p antitumor activity is achieved by targeting the SKA2 in human breast cancer cells, suggesting that miR-520d-3p may be a potential target molecule for the therapy.

Entities:  

Keywords:  SKA2; antitumor activity; breast cancer; miR-520d-3p

Year:  2018        PMID: 29736203      PMCID: PMC5934569     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  36 in total

1.  miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46.

Authors:  Wenjing Cui; Yiwen Zhang; Nan Hu; Changliang Shan; Shuai Zhang; Weiying Zhang; Xiaodong Zhang; Lihong Ye
Journal:  Cancer Biol Ther       Date:  2010-08-07       Impact factor: 4.742

2.  Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.

Authors:  Masato Nishimura; Eun-Jung Jung; Maitri Y Shah; Chunhua Lu; Riccardo Spizzo; Masayoshi Shimizu; Hee Dong Han; Cristina Ivan; Simona Rossi; Xinna Zhang; Milena S Nicoloso; Sherry Y Wu; Maria Ines Almeida; Justin Bottsford-Miller; Chad V Pecot; Behrouz Zand; Koji Matsuo; Mian M Shahzad; Nicholas B Jennings; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; George A Calin
Journal:  Cancer Discov       Date:  2013-09-03       Impact factor: 39.397

3.  Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.

Authors:  Ming Wang; Chenglong Li; Beiqin Yu; Liping Su; Jianfang Li; Jingfang Ju; Yingyan Yu; Qinlong Gu; Zhenggang Zhu; Bingya Liu
Journal:  J Gastroenterol       Date:  2013-01-22       Impact factor: 7.527

4.  MiR-424 Promotes Non-Small Cell Lung Cancer Progression and Metastasis through Regulating the Tumor Suppressor Gene TNFAIP1.

Authors:  Ming Zhang; Chang'e Gao; Yi Yang; Gaofeng Li; Jian Dong; Yiqin Ai; Qianli Ma; Wenhui Li
Journal:  Cell Physiol Biochem       Date:  2017-05-25

Review 5.  A review of clinical aspects of breast cancer.

Authors:  Shai Libson; Marc Lippman
Journal:  Int Rev Psychiatry       Date:  2014-02

6.  MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.

Authors:  Jianyong Zheng; Peng Ge; Xiaonan Liu; Jiangpeng Wei; Guosheng Wu; Xiaohua Li
Journal:  Tumour Biol       Date:  2017-06

7.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Authors:  Naoto Kondo; Tatsuya Toyama; Hiroshi Sugiura; Yoshitaka Fujii; Hiroko Yamashita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

Review 8.  MicroRNAs as potential biomarkers in cancer: opportunities and challenges.

Authors:  Huiyin Lan; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

9.  Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer.

Authors:  Ming Fan; Ting He; Peng Zhang; Juan Zhang; Lihua Li
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

10.  Cyclic AMP responsive element-binding protein promotes renal cell carcinoma proliferation probably via the expression of spindle and kinetochore-associated protein 2.

Authors:  Haihui Zhuang; Xiangyu Meng; Yanyuan Li; Xue Wang; Shuaishuai Huang; Kaitai Liu; Michael Hehir; Rong Fang; Lei Jiang; Jeff X Zhou; Ping Wang; Yu Ren
Journal:  Oncotarget       Date:  2016-03-29
View more
  8 in total

1.  Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells.

Authors:  Tamara Fernández-Calero; Marcos Davyt; Karen Perelmuter; Cora Chalar; Giovana Bampi; Helena Persson; Juan Pablo Tosar; Völundur Hafstað; Hugo Naya; Carlos Rovira; Mariela Bollati-Fogolín; Ricardo Ehrlich; Gilles Flouriot; Zoya Ignatova; Mónica Marín
Journal:  Cancer Metab       Date:  2020-07-19

2.  miR-520d suppresses rapid pacing-induced apoptosis of atrial myocytes through mediation of ADAM10.

Authors:  Qinghua Fu; Yi Tang; Jianqiang Peng; Jin He; Qiongchao Zou; Sulan Yan; Zhaofen Zheng; Hongwei Pan
Journal:  J Mol Histol       Date:  2021-02-05       Impact factor: 2.611

3.  Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.

Authors:  Yueyang Liang; Shushu Wang; Jia Liu
Journal:  J Breast Cancer       Date:  2019-04-19       Impact factor: 3.588

4.  Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.

Authors:  Yue Zhong; Zhenjie Zhuang; Peiju Mo; Mandi Lin; Jiaqian Gong; Jiarong Huang; Haiyan Mo; Yuyun Lu; Mei Huang
Journal:  PeerJ       Date:  2021-12-13       Impact factor: 2.984

Review 5.  The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review.

Authors:  Qiang Cai; Guoqing Liu; Linsheng Huang; Yuting Guan; Huixia Wei; Zhiqian Dou; Dexi Liu; Yang Hu; Meiling Gao
Journal:  Drug Des Devel Ther       Date:  2022-07-06       Impact factor: 4.319

6.  MicroRNA-520d-3p suppresses melanoma cells proliferation by inhibiting the anti-silencing function 1B histone chaperone.

Authors:  Xian Shi; Xidan Xu; Nian Shi; Yongjun Chen; Manni Fu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.

Authors:  Dongwei Dou; Xiaoyang Ren; Mingli Han; Xiaodong Xu; Xin Ge; Yuanting Gu; Xinxing Wang; Song Zhao
Journal:  Mol Oncol       Date:  2020-12-07       Impact factor: 7.449

Review 8.  ZEB2, the Mowat-Wilson Syndrome Transcription Factor: Confirmations, Novel Functions, and Continuing Surprises.

Authors:  Judith C Birkhoff; Danny Huylebroeck; Andrea Conidi
Journal:  Genes (Basel)       Date:  2021-07-03       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.